ISSN: 1935-1232 (P)

ISSN: 1941-2010 (E)


Citations Report

Clinical Schizophrenia & Related Psychoses : Citations & Metrics Report

Articles published in Clinical Schizophrenia & Related Psychoses have been cited by esteemed scholars and scientists all around the world. Clinical Schizophrenia & Related Psychoses has got h-index 41, which means every article in Clinical Schizophrenia & Related Psychoses has got 41 average citations.

Following are the list of articles that have cited the articles published in Clinical Schizophrenia & Related Psychoses.

  2022 2021 2020 2019 2018

Year wise published articles

105 141 28 8 28

Year wise citations received

543 553 590 563 587
Journal total citations count 6601
Journal Impact Factor 6.49
Journal 5 years Impact Factor 12.17
Journal CiteScore 11.19
Journal h-index 41
Journal h-index since 2016 26
Heringa, Sophie M., Marieke JH Begemann, Angelique J. Goverde, and Iris EC Sommer. "Sex hormones and oxytocin augmentation strategies in schizophrenia: a quantitative review." Schizophrenia research 168, no. 3 (2015): 603-613.
Caponnetto, Pasquale, Alessandra Benenati, and Marilena G. Maglia. "Psychopathological Impact and Resilient Scenarios in Inpatient with Schizophrenia Spectrum Disorders Related to Covid Physical Distancing Policies: A Systematic Review." Behavioral Sciences 11, no. 4 (2021): 49.
McGregor, Claire, Alexander Riordan, and Janice Thornton. "Estrogens and the cognitive symptoms of schizophrenia: Possible neuroprotective mechanisms." Frontiers in neuroendocrinology 47 (2017): 19-33.
Khosravi, Mohsen, and Alireza Ganjali. "Letter to the Editor: Burnout Management among Health Care Workers in the Age of Coronavirus Disease-19." Open Access Macedonian Journal of Medical Sciences 9, no. E (2021): 382-385.
Onu, Justus Uchenna, and Jude Uzoma Ohaeri. "Association of family history of schizophrenia and history of obstetric complications at birth: relationship with age at onset and psychopathology dimensions in a Nigerian cohort." African Health Sciences 20, no. 2 (2020): 697-708.
Çakici, N., N. J. M. Van Beveren, G. Judge-Hundal, M. M. Koola, and I. E. C. Sommer. "An update on the efficacy of anti-inflammatory agents for patients with schizophrenia: a meta-analysis." Psychological medicine 49, no. 14 (2019): 2307-2319.
Delkash, Parisa, and Roya Vaziri-Harami. "Causes of Chronic Fatigue Syndrome in Covid-19 Patients and Treatment Recommendations." Annals of the Romanian Society for Cell Biology (2021): 8460-8466.
Kulkarni, Jayashri, Emorfia Gavrilidis, Stella M. Gwini, Roisin Worsley, Jasmin Grigg, Annabelle Warren, Caroline Gurvich, Heather Gilbert, Michael Berk, and Susan R. Davis. "Effect of adjunctive raloxifene therapy on severity of refractory schizophrenia in women: a randomized clinical trial." JAMA psychiatry 73, no. 9 (2016): 947-954.
Debnath, Monojit, Ganesan Venkatasubramanian, and Michael Berk. "Fetal programming of schizophrenia: select mechanisms." Neuroscience & Biobehavioral Reviews 49 (2015): 90-104.
Khosravi, Mohsen. "Ursodeoxycholic Acid in Patients With Treatment-Resistant Schizophrenia Suffering From Coronavirus Disease 2019: A Hypothesis Letter." Frontiers in Psychiatry 12 (2021).
Mezquida, Gisela, Emilio Fernandez-Egea, Devi Treen, Anna Mané, Daniel Bergé, George Savulich, Leticia Garcia-Alvarez et al. "Obstetric phenotypes in the heterogeneity of schizophrenia." The Journal of nervous and mental disease 206, no. 11 (2018): 882-886.
EBRAHIMI, HAMIDREZA KHOSHNEZHAD, SINA SALAMI, SHABAHANG JAFARNEJAD, SEYEDEH MAHSA, MAHMOUDINEZHAD DEZFOULI, MOTAHARE AGHAJANI DELAVAR, and SOMAYEH ESMAEILIAN. "Relationship between anxiety and resilience of coronavirus (COVID-19) in pediatric and emergency assistants of Iran Medical Science University, 2021."
Heringa, Sophie M., Marieke JH Begemann, Angelique J. Goverde, and Iris EC Sommer. "Sex hormones and oxytocin augmentation strategies in schizophrenia: a quantitative review." Schizophrenia research 168, no. 3 (2015): 603-613.
Riecher-Rössler, Anita. "Oestrogens, prolactin, hypothalamic-pituitary-gonadal axis, and schizophrenic psychoses." The Lancet Psychiatry 4, no. 1 (2017): 63-72.
Gogos, Andrea, Alyssa M. Sbisa, Jeehae Sun, Andrew Gibbons, Madhara Udawela, and Brian Dean. "A role for estrogen in schizophrenia: clinical and preclinical findings." International journal of endocrinology 2015 (2015).
Gohari, Ali, Hossein Mehravaran, Ali Boustani, Mahboubeh Darban, and Sara Reshadat. "Case Report: Delayed Recurrent Spontaneous Pneumothorax Associated with COVID-19." Annals of the Romanian Society for Cell Biology (2021): 8226-8230.
Kulkarni, J., E. Gavrilidis, Wei Wang, R. Worsley, P. B. Fitzgerald, C. Gurvich, T. Van Rheenen, M. Berk, and H. Burger. "Estradiol for treatment-resistant schizophrenia: a large-scale randomized-controlled trial in women of child-bearing age." Molecular psychiatry 20, no. 6 (2015): 695-702.
AKHOUNDIMEYBODI, ZOHREH, SEYED RUHOLLAH MOUSAVINASAB, MOHAMMAD BAGHER OWLIA, and SINA OWLIA. "Effectiveness and Safety Doxycycline in treating COVID-19 Positive Patients: A pilot clinical study." Pakistan Journal of Medical and Health Sciences 15, no. 1 (2021).
De Berardis, Domenico, Michele Fornaro, Laura Orsolini, Luigi Olivieri, Francesco Nappi, Gabriella Rapini, Federica Vellante, Cosimo Napoletano, Nicola Serroni, and Massimo Di Giannantonio. "Clozapine-related sudden pericarditis in a patient taking long acting aripiprazole and valproate: a case report." Clinical Psychopharmacology and Neuroscience 16, no. 4 (2018): 505.
Sommer, Iris E., Roos van Westrhenen, Marieke JH Begemann, Lot D. de Witte, Stefan Leucht, and René S. Kahn. "Efficacy of anti-inflammatory agents to improve symptoms in patients with schizophrenia: an update." Schizophrenia bulletin 40, no. 1 (2014): 181-191.